Main Menu

Making the discoveries that defeat cancer

The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Please see the latest updates concerning our response to coronavirus.

Help kick-start our vital research

The coronavirus crisis is presenting huge challenges for us all – and we have lost vital time in our research to defeat cancer. Mother of two, Sally, is living with stage 4 melanoma. She explains why your support of our kick-start appeal is so vital.
Find out more
Computer-assisted ultrasound imaging could deliver more accurate radiotherapy

A computer algorithm which helps radiographers interpret ultrasound images could improve radiotherapy treatment for patients with prostate cancer.
Read more
Immune system could be trained to spot drug-resistant cancers

Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests.
Read more
Delivering radiotherapy in fewer doses is safe for patients with early breast cancer

A lower total dose of radiotherapy delivered in fewer but larger doses is as safe in the long term as breast cancer radiotherapy courses giving multiple small doses, according to a 10-year study.
Read more
Study strengthens calls to clear cancer diagnosis backlog

Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand additional deaths in England, a new study reports.
Read more

1/5

Innovative approaches

We will take on the challenge of cancer’s complexity, evolution and drug resistance through the discovery of innovative new approaches to cancer treatment.
Find out more
Making it count

We will deliver better outcomes and improved quality of life for patients by establishing innovative treatments, diagnostics and strategies for prevention as part of routine healthcare.
Find out more
Creating new treatments that target tumours

Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Find out more
Winner of Queen's Anniversary Prize

The ICR has been recognised with a highly prestigious Queen’s Anniversary Prize for its world-leading research in cancer drug discovery.
Read more
Unravelling cancer’s complexity

We will comprehend the full complexity of cancer by harnessing the power of new technologies and Big Data.
Find out more
Smarter, kinder treatments

We will move a step closer to cure by bringing personalised treatments into the clinic and developing them for patients.
Find out more